3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
10
Lung Neoplasms
5
Prostatic Neoplasms
4
Breast Neoplasms
4
Oropharyngeal Neoplasms
3
Neoplasms
3
Endometrial Neoplasms
3
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pleuropulmonary blastoma
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Pancreatitis, Chronic
1
Obesity
1
Neurocognitive Disorders
1
Neuroblastoma
1
Neoplasm Metastasis
1
Interventions
Rituximab
44
Cyclophosphamide
37
Prednisone
26
Doxorubicin
25
Vincristine
19
Lenalidomide
19
Magnetic Resonance Spectroscopy
18
Gemcitabine
18
Specimen Handling
17
polatuzumab vedotin
15
Oxaliplatin
14
Biopsy
14
glofitamab
13
obinutuzumab
11
Etoposide
10
ibrutinib
9
fludarabine
8
Dexamethasone
8
CT-P10
8
pembrolizumab
7
deltacortene
7
Prednisolone
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
venetoclax
6
tafasitamab
6
prednylidene
6
acalabrutinib
6
R-CHOP protocol
5
Immunotherapy, Adoptive
5
fludarabine phosphate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Observation
×
90 days
×
Clear all
No trials found.